Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention.
Yamamoto K, Morimoto T, Natsuaki M, Shiomi H, Ozasa N, Sakamoto H, Takeji Y, Domei T, Tada T, Taniguchi R, Uegaito T, Yamada M, Takeda T, Eizawa H, Suwa S, Shirotani M, Tamura T, Inoko M, Sakai H, Ishii K, Toyofuku M, Miki S, Onodera T, Furukawa Y, Inada T, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Yamamoto K, et al. Among authors: eizawa h. Circ J. 2024 May 24;88(6):888-899. doi: 10.1253/circj.CJ-23-0558. Epub 2023 Sep 15. Circ J. 2024. PMID: 37722886 Free article.
Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry.
Furukawa Y, Taniguchi R, Ehara N, Ozasa N, Haruna Y, Saito N, Doi T, Hoshino K, Shizuta S, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators. Furukawa Y, et al. Circ J. 2008 Dec;72(12):1937-45. doi: 10.1253/circj.cj-08-0293. Epub 2008 Oct 24. Circ J. 2008. PMID: 18948669 Free article.
Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization.
Furukawa Y, Ehara N, Taniguchi R, Haruna Y, Ozasa N, Saito N, Doi T, Hoshino K, Tamura T, Shizuta S, Abe M, Toma M, Morimoto T, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators. Furukawa Y, et al. Circ J. 2009 Aug;73(8):1459-65. doi: 10.1253/circj.cj-08-1083. Epub 2009 Jun 16. Circ J. 2009. PMID: 19531902 Free article.
Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2.
Tokushige A, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Ehara N, Inada T, Kaburagi S, Hamasaki S, Tei C, Nakashima H, Ogawa H, Tatami R, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Tokushige A, et al. Circ Cardiovasc Interv. 2012 Apr;5(2):237-46. doi: 10.1161/CIRCINTERVENTIONS.111.963728. Epub 2012 Mar 6. Circ Cardiovasc Interv. 2012. PMID: 22396582
Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, Inada T, Mitsuoka H, Taniguchi R, Nakano A, Kita T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Natsuaki M, et al. Circ J. 2012;76(6):1369-79. doi: 10.1253/circj.cj-11-1356. Epub 2012 Mar 15. Circ J. 2012. PMID: 22447012 Free article.
Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
Tada T, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Byrne RA, Kastrati A, Kadota K, Iwabuchi M, Shizuta S, Tazaki J, Shiomi H, Abe M, Ehara N, Mizoguchi T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, Nakano A, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Tada T, et al. Among authors: eizawa h. Circ Cardiovasc Interv. 2012 Jun;5(3):381-91. doi: 10.1161/CIRCINTERVENTIONS.111.967463. Epub 2012 May 22. Circ Cardiovasc Interv. 2012. PMID: 22619260
Distinct survival benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers in revascularized coronary artery disease patients according to history of myocardial infarction.
Nishino T, Furukawa Y, Kaji S, Ehara N, Shiomi H, Kim K, Kitai T, Kinoshita M, Morimoto T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Nishino T, et al. Circ J. 2013;77(5):1242-52. doi: 10.1253/circj.cj-12-0963. Epub 2012 Dec 29. Circ J. 2013. PMID: 23291989 Free article.
Sex-based differences in clinical practice and outcomes for Japanese patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Toyota T, Furukawa Y, Ehara N, Funakoshi S, Morimoto T, Kaji S, Nakagawa Y, Kadota K, Iwabuchi M, Shiomi H, Yamamuro A, Kinoshita M, Kitai T, Kim K, Tani T, Kobori A, Kita T, Sakata R, Kimura T; Credo-Kyoto Investigators. Toyota T, et al. Circ J. 2013;77(6):1508-17. doi: 10.1253/circj.cj-12-1161. Epub 2013 Mar 5. Circ J. 2013. PMID: 23459447 Free article. Clinical Trial.
Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2.
Tazaki J, Shiomi H, Morimoto T, Imai M, Yamaji K, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Tazaki J, et al. EuroIntervention. 2013 Aug 22;9(4):437-45. doi: 10.4244/EIJV9I4A72. EuroIntervention. 2013. PMID: 23965348 Free article.
50 results